| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $446.6M | +6.1% |
| Cost of Revenue | $114.1M | +18.4% |
| Gross Profit | $332.5M | +2.4% |
| R&D Expense | $89.9M | +16.4% |
| SG&A Expense | $63.3M | -39.7% |
| Operating Income | $44.5M | +237.3% |
| Pre-tax Income | $40.1M | +243.0% |
| Income Tax | $2.3M | +2150.0% |
| Net Income | $37.9M |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $154.1M | +25.2% |
| Accounts Receivable | $120.6M | +6.8% |
| Current Assets | $317.8M | +11.2% |
| Total Assets | $621.8M | +1.9% |
| Current Liabilities | $296.8M | -13.9% |
| Long-term Debt | $98.0M | — |
| Total Liabilities | $462.4M | +1.2% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $55.8M | +11.2% |
| Capital Expenditures | $2.6M | +22.6% |
| Investing Cash Flow | -$21.4M | +76.7% |
| Financing Cash Flow | -$9.5M | +66.6% |
| Free Cash Flow | $53.3M | +10.7% |
| +235.5% |
| EPS (Basic) | $0.31 | +240.9% |
| EPS (Diluted) | $0.07 | +131.8% |
| Stockholders' Equity |
| $159.4M |
| +4.1% |